Member Info for Prion25

Those "opinions" were intended to crash and manipulate the SP and Grizzly to profit and that in my opinion tis Fraudulent criminal activity .

Agree we need a rebuttal to the criminal activity of Grizzly by Ceres

Grizzly very astute.They wouldn’t attack a company in decline and going bust.Would they ?

Https://investing.thisismoney.co.uk/rns/news/35418917

Oxford BioDynamics has stated its plan to build a prospective observational registry study for the EpiSwitch PSE, similar to the one established for another of its tests, EpiSwitch CiRT. This future prospective study would further validate the test's performance with longitudinal data in a real-world setting.

Https://www.proactiveinvestors.co.uk/companies/news/1083270/ubs-is-bullish-on-ceres-if-the-fuel-cell-firm-can-land-at-least-one-new-partner-1083270.html?rel=scroll#

Thorn

Take a break , you must be exhausted , however pertinent your questions on the chemistry and pharmacokinetics all has been researched by our wonderful scientists Michelle and Francis who have spent years and sleepless nights collecting meticulous data from boring graphs and tables to be published in peer reviewed scientific journals which are ongoing to achieve game changing drugs Perhaps you should direct your questions to them or Q &A meetings

Has the Doosan SOFC licence with Ceres include the dual /reverse tech for electrolysis ?

That is the another benefit of Ceres SOFC is that it's fuel flexible and ensures reliability and resilience while South Korea's develops its hydrogen economy and transitions away from natural gas etc

KEPCO deal. Great endorsement of Ceres tech and a transformational boost to it's commercial traction

Also from AI FWIW

Pentwater Capital is a large, event-driven hedge fund with a strong focus on merger arbitrage, distressed and special situations, and capital structure arbitrage. Their involvement often signals that the firm anticipates a significant corporate event that could unlock value, such as a potential takeover, merger, or a major business breakthrough.

“It can only get better “ Fantastic news

India pursuing green energy aggressively but like the UK having problems with transition , grid bottleneck PPA payments etc .seems like scaremongers are looking for cheap shares ?

Cannot make head or tail of the TR1 looks like an increase by Richard Griffiths ???

Thanks explorer

Again from AI search multiple clean energy alternatives including this

On-site power generation: Equinix has partnered with alternative energy companies, including Bloom Energy, to explore and implement on-site power generation with technologies like solid-oxide fuel cells.

Thanks Cadburyhill

Just copied this from a AI search

Initial project: In 2016, Cummins and Ceres received a $4.9 million grant from the U.S. Department of Energy (DOE) to create a modular 5kW solid oxide fuel cell system for data centers.

Https://www.proactiveinvestors.co.uk/companies/news/1081359/ceres-jumps-as-ubs-sees-breakeven-next-year-1081359.html

Sounds too good to be true but they are on a cusp of ground breaking science with dual payloads offering a synergistic effect to overcome resistant tumours Fantastic

Outstanding Science worthy of a Nobel prize

Conclusion copied from the Poster

FAP-selective pre|CISION® dual payload technology enables simultaneous

delivery of two drugs from a single, stable PDC molecule via one FAP-mediated

cleavage event •Tunable kinetics of payload release may be achieved by modifications of the

linker and the capping group, as evidenced by comparison of compound A vs B

•pre|CISION® dual payload release was validated through target-and pathway

specific biomarkers •pre|CISION® dual payloads are released by FAP on cancer associated fibroblasts,

concentrating both payloads in the TME and killing tumor cells via the bystander effect

•pre|CISION® dual payload technology allows selective delivery of two payloads,

overcoming potential resistance and eliciting synergistic tumor cell kill

•Tumor-specific delivery has the potential to increase the therapeutic window and

reduce systemic toxicities, offering improved outcome for patients with cancer